Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Biddle

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|August 30, 2014
Elevation in 5-FU-induced apoptosis in head and neck cancer stem cells by a combination of CDHP and GSK3β inhibitorsHideo Shigeishi, Adrian Biddle, Luke Gammon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Bexarotene and erlotinib for aerodigestive tract cancerKonstantin H Dragnev, W Jeffrey Petty, Sumit Shah, et al.
Journal of the National Cancer Institute|November 17, 2005
A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesisW Jeffrey Petty, Na Li, Adrian Biddle, et al.
Stem Cells (Dayton, Ohio)|May 8, 2013
Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3β influenced by CD44 and RHAMMHideo Shigeishi, Adrian Biddle, Luke Gammon, et al.
Elife|November 17, 2023
Disseminating cells in human oral tumours possess an EMT cancer stem cell marker profile that is predictive of metastasis in image-based machine learningGehad Youssef, Luke Gammon, Leah Ambler, et al.
Pharmacology & Therapeutics|October 1, 2018
Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomasMohit Kumar Jolly, Jason A Somarelli, Maya Sheth, et al.
Cancers|November 13, 2025
Identification of Phenotypically Distinct Cancer Stem Cell Subpopulations in Oral Squamous Cell CarcinomaTarig Al-Hadi Osman, Oddveig Rikardsen, Muy-Teck Teh, et al.
BMC Biology|August 3, 2025
A CD24<sup>+</sup>CD271<sup>+</sup> melanoma cancer stem cell possesses hybrid characteristics of its single marker counterparts and promotes invasion and therapeutic resistanceOlivia Knowles, Patricio Doldan, Isabella Hillier-Richardson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancersW Jeffrey Petty, Konstantin H Dragnev, Vincent A Memoli, et al.
Journal of the National Cancer Institute|March 20, 2025
The NuRD-SWI/SNF antagonism regulates the coordinated activation of EMT and inflammation in oral cancerRoberto Stabile, Francesco A Tucci, Mathijs P Verhagen, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|August 30, 2014
Elevation in 5-FU-induced apoptosis in head and neck cancer stem cells by a combination of CDHP and GSK3β inhibitorsHideo Shigeishi, Adrian Biddle, Luke Gammon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Bexarotene and erlotinib for aerodigestive tract cancerKonstantin H Dragnev, W Jeffrey Petty, Sumit Shah, et al.
Journal of the National Cancer Institute|November 17, 2005
A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesisW Jeffrey Petty, Na Li, Adrian Biddle, et al.
Stem Cells (Dayton, Ohio)|May 8, 2013
Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3β influenced by CD44 and RHAMMHideo Shigeishi, Adrian Biddle, Luke Gammon, et al.
Elife|November 17, 2023
Disseminating cells in human oral tumours possess an EMT cancer stem cell marker profile that is predictive of metastasis in image-based machine learningGehad Youssef, Luke Gammon, Leah Ambler, et al.
Pharmacology & Therapeutics|October 1, 2018
Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomasMohit Kumar Jolly, Jason A Somarelli, Maya Sheth, et al.
Cancers|November 13, 2025
Identification of Phenotypically Distinct Cancer Stem Cell Subpopulations in Oral Squamous Cell CarcinomaTarig Al-Hadi Osman, Oddveig Rikardsen, Muy-Teck Teh, et al.
BMC Biology|August 3, 2025
A CD24<sup>+</sup>CD271<sup>+</sup> melanoma cancer stem cell possesses hybrid characteristics of its single marker counterparts and promotes invasion and therapeutic resistanceOlivia Knowles, Patricio Doldan, Isabella Hillier-Richardson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancersW Jeffrey Petty, Konstantin H Dragnev, Vincent A Memoli, et al.
Journal of the National Cancer Institute|March 20, 2025
The NuRD-SWI/SNF antagonism regulates the coordinated activation of EMT and inflammation in oral cancerRoberto Stabile, Francesco A Tucci, Mathijs P Verhagen, et al.
Pageof 4